Environmental

HUMA’s environmental profile is constrained by heavy R&D intensity, which can support lower-resource medical innovation, but peers often disclose clearer sustainability targets and metrics.

The company’s operating footprint appears relatively light versus industrial peers, yet limited disclosure on energy, waste, and emissions reduces comparability and weakens relative positioning.

As a healthcare technology and therapeutics business, HUMA faces lower direct environmental exposure than manufacturing peers, but its ESG standing depends more on disclosure quality than footprint size.

No material environmental controversies are evident in the provided data, but the absence of detailed environmental reporting leaves HUMA behind better-disclosed peers.

Social

HUMA’s social profile benefits from a healthcare-oriented mission, which typically aligns with patient welfare and access, but peers often provide more explicit outcome and safety reporting.

High R&D spending supports product development and clinical relevance, yet it also signals execution pressure that can affect workforce stability and stakeholder confidence versus peers.

Stock-based compensation is moderate relative to revenue, suggesting some alignment with talent retention, although peers with stronger disclosure often demonstrate clearer human-capital governance.

The provided data do not show major labor or product-safety controversies, but limited transparency on patient, employee, and community metrics keeps HUMA below stronger peers.

Governance

HUMA’s governance profile is mixed because leverage is manageable, but a debt-to-equity ratio above one still leaves it less conservative than many peers.

Stock-based compensation at roughly 5% of revenue indicates dilution pressure, which can weigh on governance quality relative to peers with tighter capital discipline.

Negative gross margin suggests the business remains in an early operating phase, making governance oversight of spending discipline and disclosure more important than at mature peers.

The available metrics do not indicate severe governance failures, but limited evidence of superior board, audit, or shareholder-rights practices keeps HUMA in the middle of the peer set.

Overall Score

HUMA ranks as a middle-of-the-pack ESG name versus peers because its healthcare mission and manageable leverage are offset by limited disclosure and capital-discipline concerns.

Score Driver: Limited ESG Disclosure Relative To Peers